Next-Generation COVID Vaccines with Pablo Penaloza-MacMaster, PhD

Next-Generation COVID Vaccines with Pablo Penaloza-MacMaster, PhD

Author: Northwestern University Feinberg School of Medicine August 31, 2021 Duration: 19:28

As the Delta variant of SARS-CoV-2 is causing breakthrough infections in some vaccinated people around the world, scientists at Northwestern Medicine are developing and studying potential next-generation COVID-19 vaccines that could be more effective at preventing and clearing breakthrough infections. Pablo Penaloza-MacMaster, assistant professor of Microbiology-Immunology at Feinberg, discusses recent studies from his lab that aim to improve current COVID-19 vaccines. 


Tune into Breakthroughs for a direct line to the labs and minds at Northwestern University Feinberg School of Medicine. Each episode pulls back the curtain on the process of discovery, letting you hear directly from the researchers themselves as they explain the questions that keep them up at night and the moments of insight that change everything. This isn't just about announcing findings; it's about understanding the human effort behind them. You'll get a clear sense of how a single study can ripple out, influencing treatments and shifting our entire approach to wellness. The conversations in this podcast are grounded in the belief that transforming medicine starts with asking better questions. From detailed explorations of cellular mechanisms to broader discussions on public health, the content connects the dots between specialized science and its real-world impact. Listen for thoughtful dialogue that makes complex topics accessible, always pointing toward a future where health is improved for entire communities. Produced by Northwestern University Feinberg School of Medicine, this series is for anyone curious about the tangible steps science is taking right now to create a healthier tomorrow.
Author: Language: English Episodes: 100

Breakthroughs
Podcast Episodes
A Vaccine Pathway for Herpes Virus with Gregory Smith, PhD [not-audio_url] [/not-audio_url]

Duration: 17:36
Gregory Smith, professor of Microbiology-Immunology at Feinberg, has been investigating a path to long-needed vaccine development for herpes virus. He recently published findings in the journal Nature that bring the poss…
Immunotherapy for Glioblastoma with Adam Sonabend, MD [not-audio_url] [/not-audio_url]

Duration: 18:46
Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma — the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD,…
COVID-19 Boosters Increase Protection with Alexis Demonbreun, PhD [not-audio_url] [/not-audio_url]

Duration: 14:50
What do we know about the effectiveness of COVID-19 boosters, and how might they better protect us from new variants such as omicron? Alexis Demonbreun, PhD, assistant professor of Pharmacology, offers insight. She is th…
Human Genome Project for Proteins with Neil Kelleher, PhD [not-audio_url] [/not-audio_url]

Duration: 18:04
Millions of molecular proteins are swimming through our body's cells and many studies have discovered that these proteins are the main drivers of all human diseases. Scientists are now mapping proteins the way the Human…
Reversing Severe Spinal Cord Injuries with Samuel Stupp, PhD [not-audio_url] [/not-audio_url]

Duration: 20:29
Regenerative nanomedicine is being used to develop new therapies for devastating conditions such as severe spinal cord injuries. Northwestern's Dr. Samuel Stupp is a pioneer in the field of regenerative nanomedicine and…
Earliest Signs of Parkinson's Disease with D. James Surmeier, PhD [not-audio_url] [/not-audio_url]

Duration: 34:27
Northwestern Medicine scientists have discovered one of the earliest signs of Parkinson's disease, proving that damaged neuronal mitochondria alone can cause symptoms of the disease, according to a study published in Nat…
Variants of Interest and of Concern with Judd Hultquist, PhD [not-audio_url] [/not-audio_url]

Duration: 22:32
This spring, the World Health Organization began using the Greek alphabet to label key variants of SARS-CoV-2. The Greek names make it easier to talk about variants with the public, but in the scientific community these…